Semnur Pharmaceuticals, Inc. (SMNR)
OTCMKTS · Delayed Price · Currency is USD
15.00
-8.00 (-34.78%)
At close: Dec 31, 2025

Semnur Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
3,4463972111
Market Cap Growth
2802.66%-45.38%-35.07%-
Enterprise Value
3,45681--
Last Close Price
15.0011.8810.1710.29
PB Ratio
-236.15-0.92-1.90-3.20
Debt / Equity Ratio
-0.67-1.15-0.99-1.02
Quick Ratio
0.010.340.010.14
Current Ratio
0.01171.290.020.37
Return on Assets (ROA)
--79.36%-278.24%-
Return on Capital (ROIC)
--90.81%-1089.91%-
Return on Capital Employed (ROCE)
1674.60%-70.50%1689.60%-664.00%
Earnings Yield
-4.50%-11.88%-4.51%-3.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.